No Data
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Elevance Health (ELV) and Genmab (GMAB)
A. G. P. Maintains NeuroSense Therapeutics(NRSN.US) With Buy Rating, Maintains Target Price $7.5
NeuroSense Therapeutics Reports Key Progress and Financials
NeuroSense Therapeutics Regains Compliance With Nasdaq Equity Requirement
Express News | Neurosense Regains Compliance With Nasdaq's Minimum Equity Requirement
Neurosense Therapeutics Files for Resale of Up to 5.28 Million Shares
Carlos Moreno138 : j8 on vrax, no cash on had what do you mien with that?
Jaguar8 OP Carlos Moreno138 : They don’t have cash to operate on
Carlos Moreno138 : so they are probably going to diluted
一定要割我吗 : I don't understand why. $Intelligent Protection Managem (IPM.US)$ No volume.
Jaguar8 OP Carlos Moreno138 : Yes but they pump before dilution. That is what is happening for most stocks. Why? Because it adds cushion for it before it plummets to still satisfy price bid requirement
View more comments...